PMV Pharmaceuticals Statistics
Total Valuation
PMVP has a market cap or net worth of $63.32 million. The enterprise value is -$62.87 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PMVP has 53.21 million shares outstanding. The number of shares has increased by 1.41% in one year.
| Current Share Class | 53.21M |
| Shares Outstanding | 53.21M |
| Shares Change (YoY) | +1.41% |
| Shares Change (QoQ) | +1.89% |
| Owned by Insiders (%) | 3.38% |
| Owned by Institutions (%) | 49.29% |
| Float | 41.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.76, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.76 |
| Quick Ratio | 10.50 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.87% and return on invested capital (ROIC) is -34.35%.
| Return on Equity (ROE) | -51.87% |
| Return on Assets (ROA) | -32.02% |
| Return on Invested Capital (ROIC) | -34.35% |
| Return on Capital Employed (ROCE) | -75.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.76M |
| Employee Count | 47 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.17% in the last 52 weeks. The beta is 1.64, so PMVP's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -29.17% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 35.87 |
| Average Volume (20 Days) | 245,897 |
Short Selling Information
The latest short interest is 1.53 million, so 2.88% of the outstanding shares have been sold short.
| Short Interest | 1.53M |
| Short Previous Month | 1.52M |
| Short % of Shares Out | 2.88% |
| Short % of Float | 3.73% |
| Short Ratio (days to cover) | 2.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -91.54M |
| Pretax Income | -84.90M |
| Net Income | -82.71M |
| EBITDA | -91.40M |
| EBIT | -91.54M |
| Earnings Per Share (EPS) | -$1.58 |
Full Income Statement Balance Sheet
The company has $129.25 million in cash and $931,000 in debt, giving a net cash position of $128.32 million or $2.41 per share.
| Cash & Cash Equivalents | 129.25M |
| Total Debt | 931,000 |
| Net Cash | 128.32M |
| Net Cash Per Share | $2.41 |
| Equity (Book Value) | 121.00M |
| Book Value Per Share | 2.28 |
| Working Capital | 120.15M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$73.05 million and capital expenditures -$70,000, giving a free cash flow of -$73.12 million.
| Operating Cash Flow | -73.05M |
| Capital Expenditures | -70,000 |
| Free Cash Flow | -73.12M |
| FCF Per Share | -$1.37 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PMVP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.41% |
| Shareholder Yield | -1.41% |
| Earnings Yield | -126.36% |
| FCF Yield | -111.72% |
Analyst Forecast
The average price target for PMVP is $5.00, which is 320.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 320.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -6.67% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |